obesity drug news today glp-1 2025 oct 27 2024 was a record year for trials and is already poised to take over 2025 ADA Highlights: A New
Description
Knockout of the GIP receptor blocks LTP potentiation in the CA1 area of the hippocampus and induces synaptic dysfunction in mice [105]
doi: 10.1210/endo.142.11.8593 51 RothJDHughesHKendallEBaronADAndersonCM
Do not flush them down the toilet
2019;181(6):R211-R234
Concerns about thyroid cancer with GLP1-RA use were first raised in the premarketing phase after studies showed increased rates of thyroid C cell tumours in rodents (1)
Death by any cause was 13% lower among patients treated with GLP-1 receptor agonists
